UMB Bank’s Dynavax Technologies DVAX Stock Holding History

UMB Bank’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-677	Closed	-$10.4K	–	2310
2025 Q4	$10.4K	Buy	677 +259	+62%	+$2.85K	﹤0.01%	1809
2025 Q3	$4.15K	Buy	418 +283	+210%	+$2.95K	﹤0.01%	1920
2025 Q2	$1.34K	Sell	135 -396	-75%	-$4.17K	﹤0.01%	2038
2025 Q1	$6.89K	Buy	531 +247	+87%	+$3.27K	﹤0.01%	1672
2024 Q4	$3.63K	Buy	284 +42	+17%	+$508	﹤0.01%	1808
2024 Q3	$2.7K	Buy	242 +91	+60%	+$1K	﹤0.01%	1906
2024 Q2	$1.7K	Buy	151 +95	+170%	+$1.11K	﹤0.01%	1840
2024 Q1	$695	Buy	+56	New	+$730	﹤0.01%	1893

Other funds holding DVAX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

UMB Bank's DVAX Position: Q1 2026 in Review

UMB Bank sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 677 shares — an estimated $10.4K sold.

UMB Bank first reported a position in DVAX in Q1 2024 and held it in 8 quarters. The position peaked at $10.4K in Q4 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

UMB Bank reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
UMB Bank sold 677 Dynavax Technologies shares in Q1 2026, an estimated $10.4K.
UMB Bank first reported a position in Dynavax Technologies in Q1 2024 and held it in 8 quarters.
UMB Bank's Dynavax Technologies position peaked at $10.4K in Q4 2025.
1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on UMB Bank's 13F filing for Q1 2026, filed 11 May 2026.